Catalyst Wire Dossier Catalyst Wire Dossier

Lymphoseek

tilmanocept · Navidea Biopharmaceuticals
Drug timelines are a Plus or Pro feature.

18 regulatory and trial events tracked for Lymphoseek, covering 2013-03-13 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Repurposing Tilmanocept for Cardiac Sarcoidosis [Phase 2]

See pricing